{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:02:59Z","timestamp":1782478979636,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"crossref","award":["18-0356"],"award-info":[{"award-number":["18-0356"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"crossref","award":["198149-2018"],"award-info":[{"award-number":["198149-2018"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>(Neo-)adjuvant chemotherapy for breast cancer has a deleterious impact on muscle tissue resulting in reduced cardiorespiratory fitness, skeletal muscle mass and function. Physical exercise during treatment may counteract some of these negative effects. However, the effects of resistance training (RT) alone have never been explored. The present study aims to investigate if heavy-load RT during (neo-)adjuvant chemotherapy counteracts deleterious effects on skeletal muscle in women diagnosed with breast cancer. We hypothesize that (neo-)adjuvant treatment with chemotherapy will reduce muscle fiber size, impair mitochondrial function, and increase indicators of cellular stress and that RT during treatment will counteract these negative effects. We also hypothesize that RT during (neo-)adjuvant chemotherapy will increase muscle and blood levels of potential antitumor myokines and reduce treatment-related side effects on muscle strength and cardiorespiratory fitness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Fifty women recently diagnosed with breast cancer scheduled to start (neo-)adjuvant chemotherapy will be randomized to either randomized to either intervention group or to control group.<\/jats:p>\n            <jats:p>The intervention group will perform supervised heavy-load RT twice a week over the course of chemotherapy (approximately 16-weeks) whereas the control group will be encouraged to continue with their usual activities. Muscle biopsies from <jats:italic toggle=\"yes\">m. vastus lateralis<\/jats:italic> will be collected before the first cycle of chemotherapy (T0), after chemotherapy (T1), and 6 months later (T2) for assessment of muscle cellular outcomes. The primary outcome for this study is muscle fiber size. Secondary outcomes are: regulators of muscle fiber size and function, indicators of cellular stress and mitochondrial function, myokines with potential antitumor effects, muscle strength, and cardiorespiratory fitness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>Ethical approval has been obtained from the Regional Ethical Review Board in Uppsala, Sweden (Dnr:2016\/230\/2). Results will be disseminated through presentations at scientific meetings, publications in peer-reviewed journals, social media, and patient organizations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration number:<\/jats:title>\n            <jats:p>NCT04586517.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024960","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:03:41Z","timestamp":1615511021000},"page":"e24960","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Effects of heavy-load resistance training during (neo-)adjuvant chemotherapy on muscle cellular outcomes in women with breast cancer"],"prefix":"10.1097","volume":"100","author":[{"given":"Emelie","family":"Strandberg","sequence":"first","affiliation":[{"name":"Department of Public Health and Caring Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karianne","family":"Vassbakk-Svindland","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Henriksson","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Sciences"},{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Vikmoen","sequence":"additional","affiliation":[{"name":"Department of Physical Performance, Norwegian School of Sport Science, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kudr\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Schauer","sequence":"additional","affiliation":[{"name":"Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Lindman","sequence":"additional","affiliation":[{"name":"Department of Oncology, Uppsala University Hospital, Uppsala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"W\u00e4rnberg","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sveinung","family":"Berntsen","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Sciences"},{"name":"Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Demmelmaier","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nordin","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls","family":"Raastad","sequence":"additional","affiliation":[{"name":"Department of Physical Performance, Norwegian School of Sport Science, Oslo, Norway"},{"name":"Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12609-012-0097-1","article-title":"Chemotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer: an overview","volume":"5","author":"Andreopoulou","year":"2013","journal-title":"Curr Breast Cancer Rep"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90315-1","article-title":"Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases","volume":"62","author":"Von Hoff","year":"1977","journal-title":"Am J Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e000432","DOI":"10.1161\/JAHA.113.000432","article-title":"Cardiorespiratory fitness in breast cancer patients: a call for normative values","volume":"3","author":"Peel","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2011.39.9014","article-title":"Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum","volume":"30","author":"Jones","year":"2012","journal-title":"J Clin Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13105-012-0200-0","article-title":"Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function","volume":"69","author":"Hayward","year":"2013","journal-title":"J Physiol Biochem"},{"key":"R7-20250504","first-page":"2023","article-title":"Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat","volume":"31","author":"Hydock","year":"2011","journal-title":"Anticancer Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.bjc.6604858","article-title":"Direct effects of doxorubicin on skeletal muscle contribute to fatigue","volume":"100","author":"van Norren","year":"2009","journal-title":"Br J Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.freeradbiomed.2013.08.191","article-title":"The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle","volume":"65","author":"Gilliam","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/sms.12543","article-title":"Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy","volume":"26","author":"Nilsen","year":"2016","journal-title":"Scand J Med Sci Sports"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/bjc.2014.273","article-title":"Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial","volume":"111","author":"Christensen","year":"2014","journal-title":"Br J Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"C744","DOI":"10.1152\/ajpcell.00002.2018","article-title":"Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress","volume":"315","author":"Guigni","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1096\/fj.201700968R","article-title":"Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer","volume":"32","author":"Mijwel","year":"2018","journal-title":"FASEB J"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1078155215627502","article-title":"Taxane-induced arthralgia and myalgia: a literature review","volume":"23","author":"Chiu","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3747\/co.v17i4.562","article-title":"Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey","volume":"17","author":"Saibil","year":"2010","journal-title":"Curr Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(12)61031-9","article-title":"Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy","volume":"380","author":"Lee","year":"2012","journal-title":"Lancet"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11764-020-00856-0","article-title":"Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the pathways study","author":"Shi","year":"2020","journal-title":"J Cancer Surviv"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejca.2011.08.005","article-title":"Physical activity in a German breast cancer patient cohort: one-year trends and characteristics associated with change in activity level","volume":"48","author":"Huy","year":"2012","journal-title":"Eur J Cancer"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-019-05352-3","article-title":"Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review","volume":"177","author":"Aleixo","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"R22-20250504","first-page":"126","article-title":"Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research","volume":"100","author":"Caspersen","year":"1985","journal-title":"Public Health Rep"},{"key":"R23-20250504","first-page":"CD005001","article-title":"Exercise for women receiving adjuvant therapy for breast cancer","author":"Furmaniak","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12094-014-1184-8","article-title":"Running away from side effects: physical exercise as a complementary intervention for breast cancer patients","volume":"17","author":"Casla","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdt551","article-title":"Muscle dysfunction in cancer patients","volume":"25","author":"Christensen","year":"2014","journal-title":"Ann Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PPO.0000000000000096","article-title":"Effects of exercise on tumor physiology and metabolism","volume":"21","author":"Pedersen","year":"2015","journal-title":"Cancer J"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1249\/01.MSS.0000048831.15016.2A","article-title":"Concurrent validation of the OMNI perceived exertion scale for resistance exercise","volume":"35","author":"Robertson","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2340\/1650197719702239298","article-title":"Perceived exertion as an indicator of somatic stress","volume":"2","author":"Borg","year":"1970","journal-title":"Scand J Rehabil Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12885-017-3197-5","article-title":"Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome","volume":"17","author":"Berntsen","year":"2017","journal-title":"BMC Cancer"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The multidimentional fatigue nventory (MFI) psychometric qualities of an instrument to assess fatigue","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.1991.9.11.2042","article-title":"The calculation of actual or received dose intensity: a comparison of published methods","volume":"9","author":"Longo","year":"1991","journal-title":"J Clin Oncol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00432-019-02911-5","article-title":"Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy","volume":"145","author":"Moller","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17987\/jcsm-cr.v2i1.26","article-title":"Lean body mass, muscle fibre size and muscle function in cancer patients during chemotherapy and 10\u200aweeks of exercise","volume":"2","author":"Lonbro S","year":"2017","journal-title":"JCSM Clin Rep"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1200\/JCO.2014.59.1081","article-title":"Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial","volume":"33","author":"van Waart","year":"2015","journal-title":"J Clin Oncol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10549-018-4663-8","article-title":"Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial","volume":"169","author":"Mijwel","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-017-4571-3","article-title":"Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial","volume":"168","author":"Mijwel","year":"2018","journal-title":"Breast Cancer Res Treat"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:03:22Z","timestamp":1746338602000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024960","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"2021-02-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}